These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 15515777)
1. Serum soluble CD30 levels in Behçet's disease. Düzgün N; Ayaslioglu E; Tutkak H Clin Exp Rheumatol; 2004; 22(4 Suppl 34):S17-20. PubMed ID: 15515777 [TBL] [Abstract][Full Text] [Related]
2. Vitamin D modulates peripheral immunity in patients with Behçet's disease. Hamzaoui K; Ben Dhifallah I; Karray E; Sassi FH; Hamzaoui A Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S50-7. PubMed ID: 20868571 [TBL] [Abstract][Full Text] [Related]
3. Anti-tumor necrosis factor-alpha response in rheumatoid arthritis is associated with an increase in serum soluble CD30. Gerli R; Lunardi C; Bocci EB; Bobbio-Pallavicini F; Schillaci G; Caporali R; Bistoni O; Pirro M; Pitzalis C; Montecucco C J Rheumatol; 2008 Jan; 35(1):14-9. PubMed ID: 18061981 [TBL] [Abstract][Full Text] [Related]
4. Th1 polarization of the immune response in uveitis in Behçet's disease. Ilhan F; Demir T; Türkçüoğlu P; Turgut B; Demir N; Gödekmerdan A Can J Ophthalmol; 2008 Feb; 43(1):105-8. PubMed ID: 18204495 [TBL] [Abstract][Full Text] [Related]
5. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation? Pay S; Abbasov T; Erdem H; Musabak U; Simsek I; Pekel A; Akdogan A; Sengul A; Dinc A Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S70-5. PubMed ID: 17949555 [TBL] [Abstract][Full Text] [Related]
6. Serum levels of soluble CD30 in patients with atopic dermatitis: correlations with age, disease duration and severity. El Mongy S; Metwaly SS; Arafat MS; Hady HA Egypt J Immunol; 2008; 15(1):123-9. PubMed ID: 20306677 [TBL] [Abstract][Full Text] [Related]
7. Passage from normal mucosa to adenoma and colon cancer: alteration of normal sCD30 mechanisms regulating TH1/TH2 cell functions. Contasta I; Berghella AM; Pellegrini P; Adorno D Cancer Biother Radiopharm; 2003 Aug; 18(4):549-57. PubMed ID: 14503949 [TBL] [Abstract][Full Text] [Related]
8. Soluble CD30 serum levels in atopic dermatitis and bronchial asthma and its relationship with disease severity in pediatric age. Heshmat NM; El-Hadidi ES Pediatr Allergy Immunol; 2006 Jun; 17(4):297-303. PubMed ID: 16771784 [TBL] [Abstract][Full Text] [Related]
9. Effect of fluticasone propionate on soluble CD30 release in patients with severe allergic asthma. Purello-D'Ambrosio F; Gangemi S; Ruello G; Marotta G; Merendino RA J Investig Allergol Clin Immunol; 2000; 10(5):283-5. PubMed ID: 11108439 [TBL] [Abstract][Full Text] [Related]
10. Circulating soluble-CD30 (sCD30) in patients with HCV-related chronic hepatitis and in patients with alcoholic liver disease. De Lazzari F; Ravagnan P; Tenderini M; Vicarioto MA; Galliani EA; Lorenzoni U; Popovic A; Floreani A Hepatogastroenterology; 2002; 49(43):231-4. PubMed ID: 11941962 [TBL] [Abstract][Full Text] [Related]
11. Circulating soluble CD28 in patients with Behçet's disease: relationship to clinical manifestations. Hamzaoui K; Hamzaoui A; Bouajina L; Houman H Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S49-52. PubMed ID: 16273764 [TBL] [Abstract][Full Text] [Related]
13. Imbalance of Th17 to Th1 cells in Behçet's disease. Kim J; Park JA; Lee EY; Lee YJ; Song YW; Lee EB Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S16-9. PubMed ID: 20868565 [TBL] [Abstract][Full Text] [Related]
14. Serum galectin-3 and galectin-3 binding protein levels in Behçet's disease and their association with disease activity. Lee YJ; Kang SW; Song JK; Park JJ; Bae YD; Lee EY; Lee EB; Song YW Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S41-5. PubMed ID: 17949550 [TBL] [Abstract][Full Text] [Related]
15. CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome: evidence for a T helper 2-mediated condition. Chilosi M; Facchetti F; Notarangelo LD; Romagnani S; Del Prete G; Almerigogna F; De Carli M; Pizzolo G Eur J Immunol; 1996 Feb; 26(2):329-34. PubMed ID: 8617299 [TBL] [Abstract][Full Text] [Related]
16. Plasma sCD26 and sCD30 levels in cutaneous leishmaniasis. Jafari-Shakib R; Shokrgozar MA; Nassiri-Kashani M; Malakafzali B; Nikbin B; Khamesipour A Acta Trop; 2009 Jan; 109(1):61-3. PubMed ID: 18983807 [TBL] [Abstract][Full Text] [Related]
17. Association of CD30 transcripts with Th1 responses and proinflammatory cytokines in patients with end-stage renal disease. Velásquez SY; Opelz G; Rojas M; Süsal C; Alvarez CM Hum Immunol; 2016 May; 77(5):403-10. PubMed ID: 26970513 [TBL] [Abstract][Full Text] [Related]
18. Serum soluble CD30 in early arthritis: a sign of inflammation but not a predictor of outcome. Savolainen E; Matinlauri I; Kautiainen H; Luosujärvi R; Kaipiainen-Seppänen O Clin Exp Rheumatol; 2008; 26(5):922-5. PubMed ID: 19032830 [TBL] [Abstract][Full Text] [Related]
19. The expression of transmembrane and soluble CXCL16 and the relation with interferon-alpha secretion in patients with Behçet's disease. Yilmaz S; Cinar M; Pekel A; Simsek I; Musabak U; Erdem H; Pay S Clin Exp Rheumatol; 2013; 31(3 Suppl 77):84-7. PubMed ID: 24064021 [TBL] [Abstract][Full Text] [Related]
20. Soluble CD30 in normal pregnancy, pre-eclampsia and recurrent pregnancy loss. Gharesi-Fard B; Jafarzadeh L; Zolghadri J; Haghbin H Iran J Immunol; 2012 Dec; 9(4):234-40. PubMed ID: 23268289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]